Evidence map›Paper›PMID 27383702›Full record

ArticleJournal of applied oral science : revista FOB

Selective 5-HT7 receptor agonists LP 44 and LP 211 elicit an analgesic effect on formalin-induced orofacial pain in mice.

Kadriye Demirkaya, Özlem Martı Akgün, Buğra Şenel, Zeynep Öncel Torun, Melik Seyrek, Enza Lacivita, Marcello Leopoldo, Ahmet Doğrul

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Journal of applied oral science : revista FOB. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Novel Dual 5-HTPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Serotonergic 5-HTCurrent neuropharmacology · 2023
    Review
  4. Central nervous system effects of 5-HTMolecular medicine (Cambridge, Mass.) · 2022
    Review
  5. 5-HTFrontiers in molecular neuroscience · 2022
    Article
  6. Psychotropic Drugs for the Management of Chronic Pain and Itch.Pharmaceuticals (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kadriye Demirkaya- Gulhane Medical Academy, Department of Restorative Dentistry and Endodontics, Ankara, Turkey.
Özlem Martı Akgün- Gulhane Medical Academy, Department of Pediatric Dentistry, Ankara, Turkey.
Buğra Şenel- Gulhane Medical Academy, Department of Dentomaxillofacial Radiology, Ankara, Turkey.
Zeynep Öncel Torun- Gulhane Medical Academy, Department of Restorative Dentistry and Endodontics, Ankara, Turkey.
Melik Seyrek- Gulhane Medical Academy, Department of Pharmacology and Pain Research Centre, Ankara, Turkey.
Enza Lacivita- Università degli studi di Bari Aldo Moro, Dipartimento di Farmacia - Scienze del Farmaco, Bari, Italy.
Marcello Leopoldo- Università degli studi di Bari Aldo Moro, Dipartimento di Farmacia - Scienze del Farmaco, Bari, Italy.
Ahmet Doğrul- Gulhane Medical Academy, Department of Pharmacology and Pain Research Centre, Ankara, Turkey.
Gülhane Askerî Tıp Akademisi · TRUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the antinociceptive effects of pharmacological activation of 5-HT7 receptors on orofacial pain in mice. MATERIAL AND

methodsNociception was evaluated by using an orofacial formalin test in male Balb-C mice. Selective 5-HT7 receptor agonists, LP 44 and LP 211 (1, 5, and 10 mg/kg), were given intraperitoneally 30 min prior to a formalin injection. A bolus of 10 µl of 4% subcutaneous formalin was injected into the upper lip of mice and facial grooming behaviors were monitored. The behavioral responses consisted of two distinct periods, the early phase corresponding to acute pain (Phase I: 0-12 min) and the late phase (Phase II: 12-30 min).

resultsLP 44 and LP 211 (1, 5, and 10 mg/kg) produced an analgesic effect with reductions in face rubbing time in both Phase I and Phase II of the formalin test.

conclusionOur results suggest that 5-HT7 receptor agonists may be promising analgesic drugs in the treatment of orofacial pain.

Indexed as

Receptors, SerotoninAnalgesicsAnimalsDisease Models, AnimalDose-Response Relationship, DrugFacial PainFormaldehydeMaleMiceMice, Inbred BALB CPiperazinesReproducibility of ResultsSerotonin Receptor AgonistsSubstantia GelatinosaTime FactorsTreatment OutcomeAnalgesicsFormaldehydeN-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamidePiperazinesReceptors, Serotoninserotonin 7 receptorSerotonin Receptor Agonists

Identifiers

PMID27383702
PMCPMC5022221
OpenAlexW2469331251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.